(Incyte Corp)

	INCY latest price $139.4800 (-0.29%) ($138.3800 - $141.3400) on Tue. Mar. 28, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.5% (three month average)
RSI	60
Latest Price	$139.4800(-0.29%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	INCY declines -0.2% a day on average for past five trading days.
Weekly Trend	INCY declines -2% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support INCY advance at 0% a week (0% probability)   IBB(59%)    XBI(50%)    XLV(45%)    ARKG(43%)    IVW(43%)
Factors Impacting INCY price	INCY will decline at least -1.25% in a week (0% probabilities).   VIXM(-12%)    UUP(-9%)    TLT(-5%)    IPO(-4%)    SHY(-1%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.25% (StdDev 2.5%)
Hourly BBV	0 ()
Intraday Trend	0%

Resistance Level	$141.82
5 Day Moving Average	$139.85(-0.26%)
10 Day Moving Average	$143.48(-2.79%)
20 Day Moving Average	$141.82(-1.65%)
To recent high	-8.6%
To recent low	39.1%
Market Cap	$30.416b

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

getNextHourMoveProbability failed